Full Text
PMU110 OPTIMIZING EARLY ACCESS THROUGH ITALY'S PHARMACEUTICAL INNOVATION SYSTEM: KEY SUCCESS FACTORS FOR ATTAINING INNOVATIVE AND CONDITIONALLY INNOVATIVE STATUS

Abstract

Authors

S. Sligh A. Kravetz

Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×